Cognizant Communication launches 'Cell Medicine' open access journal

Aug 30 2010

A new and unique journal on cell transplantation aimed at helping translate laboratory findings into clinical applications is being launched by Cognizant Communication Corporation (www.cognizantcommunication.com) as a companion journal to Cell Transplantation. Cell Medicine, an online-only, open access journal, publishes research papers that promise to have direct clinical relevance. The journal is freely accessible at: http://www.ingentaconnect.com/content/cog/cm.

"This journal will offer critical evaluation of cell medicine as a safe and effective treatment for human disorders, many of which are debilitating and many times fatal," said Dr. Paul Sanberg, executive editor of the new journal and director of the University of South Florida's Center of Excellence in Aging and Brain Repair.

According to Dr. Sanberg, the list of new stem cell sources is growing to include those derived from the embryo; fetus; umbilical cord; placenta; amniotic fluid; bone marrow; fat cells; skin; and menstrual blood, among others. Acquiring a patient-specific set of stem cells is a key to the success of cell medicine, he said. In addition, the international focus of the journal originates from the many translational studies of cell transplantation occurring around the world.

Cell Medicine has a widely diverse and global editorial board drawn from academia, the biomedical industry and regulatory agencies - experts engaged in the science and translation of a cell product as it emerges from the laboratory and makes its way into clinical practice. The journal fills a public information gap as many of the findings of biomedical companies are published in in-house publications, as are guidelines and other information generated by regulatory agencies. Once more, there has been a desire on the part of researchers to be able to publish findings that they present at meetings and the journal addresses that need.

"Our goal is to not only promote translational research, but also, after fair and rapid peer review, to publish those papers on cell therapy with direct clinical relevance," concluded Dr. Sanberg.

Papers appearing in the inaugural issue of Cell Medicine highlight the international nature of the work published in Cell Medicine and they include:

• "Cell Therapy from Bench to Bedside Translation in the CNS Neurorestoratology Era." (Huang et al; China/USA)
• "New Strategies for Acute Liver-Failure: Focus on Xenotransplantation Therapy," (Alves et al; Brazil)
• "Purification and Characterization of Adipose-derived Stem Cells from Patients with Lipoaspirate Transplant" (Folgeiro et al; Italy)
• "Liver Cell Culture Devices" (Andria et al; Italy/Netherlands)

The editorial offices for CELL MEDICINE are at the Center of Excellence for Aging and Brain Repair, College of Medicine, the University of South Florida.

Source: Cell Transplantation Center of Excellence for Aging and Brain Repair